Company: PTPI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001410578-25-000579
Chunk: 9

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 15E
Chunk 9
---
ITEM 15.EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)(1) Financial Statements

The documents listed below are filed as part of this Form 10-K:

 Page Report of Independent Registered Public Accounting Firm (Firm ID # 688)F-1Consolidated Balance Sheets as of December 31, 2024, and December 31, 2023F-2Consolidated Statements of Operations for the years ended December 31, 2024, and December 31, 2023F-3Consolidated Statements of Changes in Convertible Redeemable Preferred Stock and Stockholders’ Equity/(Deficit) for the years ended December 31, 2024, and December 31, 2023F-4Consolidated Statements of Cash Flows for the years ended December 31, 2024, and December 31, 2023F-5Notes to Consolidated Financial StatementsF-6

​

(a)(2) Consolidated Financial Statement Schedules:

Schedules not filed are omitted because of the absence of the conditions under which they are required or because the required information is included in the consolidated financial statements or the notes thereto.

​